EMPA-REG RENAL Trademark

Trademark Overview

On Tuesday, February 23, 2021, a trademark application was filed for EMPA-REG RENAL with the United States Patent and Trademark Office. The USPTO has given the EMPA-REG RENAL trademark a serial number of 90542415. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 3, 2023. This trademark is owned by Boehringer Ingelheim International GmbH. The EMPA-REG RENAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of diabetes and cardiovascular diseases; Providing medical and scientific research information in the field of diabetes and cardiovascular diseases
empa-reg renal

General Information

Serial Number90542415
Word MarkEMPA-REG RENAL
Filing DateTuesday, February 23, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, January 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2021

Trademark Statements

Disclaimer with Predetermined Text"RENAL"
Goods and ServicesMedical and scientific research in the field of diabetes and cardiovascular diseases; Providing medical and scientific research information in the field of diabetes and cardiovascular diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 24, 2021
Primary Code042
First Use Anywhere DateMonday, June 16, 2014
First Use In Commerce DateMonday, June 16, 2014

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIngelheim 55218
DE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIngelheim 55218
DE

Trademark Events

Event DateEvent Description
Tuesday, January 3, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, January 3, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, January 3, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 7, 2022ASSIGNED TO EXAMINER
Friday, June 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 3, 2022NON-FINAL ACTION E-MAILED
Friday, June 3, 2022SU - NON-FINAL ACTION - WRITTEN
Saturday, May 7, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, March 14, 2022USE AMENDMENT FILED
Friday, May 6, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 14, 2022TEAS STATEMENT OF USE RECEIVED
Monday, January 24, 2022ASSIGNED TO EXAMINER
Tuesday, December 28, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 23, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, September 23, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 23, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, September 23, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, September 16, 2021ASSIGNED TO EXAMINER
Monday, May 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 26, 2021NEW APPLICATION ENTERED

Related Keywords

renal empa cardiovascular diseases medical diabetes field scientific research information providing